Neutrophil-to-Lymphocyte Ratio for Risk Stratification in Acute Myocarditis Across the Left Ventricular Ejection Fraction Spectrum
European Journal of Heart Failure · 2025
DOI: 10.1002/ejhf.70072 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift European Journal of Heart Failure, 2025. Verfasst von Cristina Madaudo und 37 weiteren Autor:innen. Beteiligte Einrichtung: King's College London British Heart Foundation Centre of Excellence, School of Cardiovascular Medicine & Sciences, London, UK. Hauptthemen laut MEDLINE: Myocarditis, Stroke Volume, Neutrophils, Lymphocytes. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council Clinician Scientist Fellowship, King's BHF Centre of Research Excellence, British Heart Foundation.
Abstract (Originalsprache)
Aims
Acute myocarditis (AM) is a heterogeneous clinical condition. Several classification models have been proposed to predict adverse clinical outcomes, but risk stratification remains challenging, particularly for patients presenting with preserved left ventricular ejection fraction (LVEF). Neutrophil-to-lymphocyte ratio (NLR) is a useful tool for risk stratification in patients with AM. This study aimed to compare the predictive accuracy of available risk stratification models, including NLR, for identifying patients with AM at increased risk of adverse events. Methods and results The study included 1150 patients with biopsy- or cardiac magnetic resonance (CMR)-proven AM from 10 hospitals in six countries. Baseline clinical, laboratory, echocardiographic and CMR data, and clinical outcomes, were collected. The population was divided into four groups based on published models of high-risk AM (complicated, fulminant, high-risk, and NLR ≥4). The primary outcome was all-cause mortality and heart transplantation. During a median follow-up of 228 weeks (interquartile range 114–339), 63 events occurred in 60 patients (5.2%) who experienced the primary outcome. NLR (area under the curve [AUC] 0.72) performed similarly to complicated (AUC 0.73) and high-risk definitions (AUC 0.73) for the prediction of adverse events, while the fulminant classification showed significantly inferior predictive accuracy (AUC 0.62, p = 0.02). Moreover, among patients with preserved LVEF (≥50%) at presentation, NLR showed superior prognostic value (AUC 0.73; complicated: 0.52, p = 0.001; high-risk: 0.52, p = 0.002). Multivariable analysis confirmed that each classification was independently associated with the primary outcome. However, the NLR model showed better predictive performance compared to the other models among patients with LVEF ≥50%.
Conclusions
While traditional definitions of high-risk AM remain valuable, NLR ≥4 is a simple and cost-effective marker that aids in risk stratification. NLR ≥4 is particularly robust in patients with preserved LVEF, supporting its use across the LVEF spectrum.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- King's College London British Heart Foundation Centre of Excellence, School of Cardiovascular Medicine & Sciences, London, UK.
- Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (ProMISE) University of Palermo, Palermo, Italy.
- Cardiovascular Division, Chaim Sheba Medical Center, Tel Hashomer. The Faculty of Medicine, Tel-Aviv University, Ramat-Gan, Israel.
- Department of Cardiology, Sahlgrenska University Hospital, Gothenburg, Sweden.
- Department of Molecular and Clinical Medicine, Institute of Medicine at Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
- CardioThoracoVascular Department, Azienda Sanitaria Universitaria Giuliano-Isontina, Trieste, Italy.
ORCID-Profile: Cristina Madaudo, Antonio Cannata
Förderung
- Medical Research Council Clinician Scientist Fellowship
- King's BHF Centre of Research Excellence
- British Heart Foundation
Zitieren
APA
Madaudo, C., Segev, A., Bobbio, E., Baggio, C., Schütze, J., Gentile, P., Sanguineti, M., Monzo, L., Schettino, M., Ferone, E., Elsanhoury, A., Younis, A., Palazzini, M., Ferroni, A., Giani, V., Sadler, M., Albarjas, M., Calò, L., Polte, C. L., …, & CAIR Collaboration (2025). Neutrophil-to-Lymphocyte Ratio for Risk Stratification in Acute Myocarditis Across the Left Ventricular Ejection Fraction Spectrum. European Journal of Heart Failure. https://doi.org/10.1002/ejhf.70072
Vancouver
Madaudo C, Segev A, Bobbio E, Baggio C, Schütze J, Gentile P, et al. Neutrophil-to-Lymphocyte Ratio for Risk Stratification in Acute Myocarditis Across the Left Ventricular Ejection Fraction Spectrum. European Journal of Heart Failure. 2025. doi:10.1002/ejhf.70072
BibTeX
@article{Madaudo2025,
author = {Madaudo, Cristina and Segev, Amitai and Bobbio, Emanuele and Baggio, Chiara and Schütze, Jonathan and Gentile, Piero and Sanguineti, Marta and Monzo, Luca and Schettino, Matteo and Ferone, Emma and Elsanhoury, Ahmed and Younis, Anan and Palazzini, Matteo and Ferroni, Adriana and Giani, Valentina and Sadler, Matthew and Albarjas, Mohammad and Calò, Leonardo and Polte, Christian Lars and Garascia, Andrea and Figliozzi, Stefano and Scott, Paul A and Shah, Ajay M and Galassi, Alfredo Ruggero and Giacca, Mauro and Sinagra, Gianfranco and Bollano, Entela and McDonagh, Theresa and Tschöpe, Carsten and Novo, Giuseppina and Ammirati, Enrico and Beigel, Roy and Gräni, Christoph and Merlo, Marco and Ameri, Pietro and Cannata, Antonio and Bromage, Daniel I and CAIR Collaboration, CAIR Collaboration},
title = {Neutrophil-to-Lymphocyte Ratio for Risk Stratification in Acute Myocarditis Across the Left Ventricular Ejection Fraction Spectrum},
journal = {European Journal of Heart Failure},
year = {2025},
doi = {10.1002/ejhf.70072}
}
EUVIMED